Single Centre Experience with Prolonged Waiting Time on Transplant List with “High-Urgency” Status

Abstract

Introduction The waiting list for heart transplantation (HTx) in Eurotransplant area has grown to a record size of nearly 1,300 patients, whereas only around 600 hearts were transplanted last year. The prolonged time for patients awaiting HTx on the high-urgency (HU) status leads mostly to serious medical complications.

Objective The aim of this study was to study the trend of changes in the frequency of ventricular assist device (VAD) implantation in patients on the HU status.

Methods A total of 22 adult patients awaiting transplantation on the HU status at our hospital between January 2011 and December 2011 were analyzed, assessing risk profile, blood group, and complication rates in terms of VAD implantation or death. Results were compared with 16 consecutive patients who were on transplant list with the HU status between January 2010 and December 2010 at our institution.

Results Mean age was 49.5 ± 12.1 (2010 group) years and 51.4 ± 10.7 years (2011 group; p = 0.62). Mean logEuroSCORES raised not significantly from 9.1 ± 6.3% (2010 group) to 10.7 ± 14.7% (2011 group; p = 0.68). Six patients died on the HU status and seven patients had to be supplied with a VAD in 2011. In comparison with the preceding year, only two patients died in 2010 and none of our patients on the HU status had to be provided with mechanical circulatory support.

Conclusion Because of the prolonged waiting time on the HU list, the earlier-mentioned data demonstrate a negative trend in transplant medicine. Especially when taking into consideration that five of seven patients who needed a VAD implantation during the HU waiting period had blood group O. Furthermore, the data derived from Eurotransplant show that the waiting period for patients with blood group O was considerably longer when compared with patients of the same average body height and weight but with other blood groups.

Keywords

transplantation - heart - circulatory assist devices - database

• References

• 1 Williams ML, Trivedi JR, McCants KC , et al. Heart transplant vs left ventricular assist device in heart transplant-eligible patients. Ann Thorac Surg 2011; 91 (5) 1330-1333, discussion 1333–1334
• 2 Smits JM, Rahmel A, Laufer G, Meiser B. Considerations for patients awaiting heart transplantation. Thorac Cardiovasc Surg 2010; 58 (Suppl. 02) S179-S184
• 3 Patarroyo M, Simbaqueba C, Shrestha K , et al. Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary era. J Heart Lung Transplant 2012; 31 (3) 282-287
• 4 Komoda T, Drews T, Lehmkuhl HB, Hetzer R. Role of ventricular assist devices in the German heart allocation system. J Artif Organs 2006; 9 (1) 29-33
• 5 Osaki S, Edwards NM, Johnson MR , et al. Improved survival after heart transplantation in patients with bridge to transplant in the recent era: a 17-year single-center experience. J Heart Lung Transplant 2009; 28 (6) 591-597
• 6 Sindermann JR, Klotz S, Rahbar K, Hoffmeier A, Drees G. German disease management guidelines: surgical therapies for chronic heart failure. Thorac Cardiovasc Surg 2010; 58 (Suppl. 02) S189-S193
• 7 Birks EJ, Tansley PD, Hardy J , et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006; 355 (18) 1873-1884
• 8 Kirklin JK, Naftel DC, Kormos RL , et al. The Fourth INTERMACS Annual Report: 4,000 implants and counting. J Heart Lung Transplant 2012; 31 (2) 117-126